rituximab
biogen,roche
['ritux', 'imab ']
#epidemiology abstracts #acr22 0720. risk-benefit assessment of primary prophylaxis for pneumocystis pneumonia in pts with rmds exposed to rituximab multicenter cohort study beneficial when a rtx combined w high-dose glucocorticoid treatment. #acrambassador
Rheumatologist | Epi | ASAS | Twitter Ambassador (ACR/ ARD-BMJ) | ArLAR ARCH President | St Joseph University & HDF Beirut | Love Music | Travel Books